Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) are both recommended, first-line treatments for hypertension, or high blood pressure.
Two blood pressure-lowering drug classes, called ACE inhibitors and ARBs, came under scrutiny after the US Centers for Disease Control and Prevention reported in April that 72 per cent of hospitalized COVID-19 patients 65 or older had hypertension.